Primary liver cancer is a significant health problem worldwide. Hepatocellular carcinoma
(HCC) is the main pathological type of primary liver cancer, accounting for 75%− 85% of …

Abstract Since 2018, N-nitrosodimethylamine (NDMA) has been a reported contaminant in
numerous pharmaceutical products. To guide the pharmaceutical industry, FDA identified an …

Objective Lung metastasis is a common and fatal complication of liver transplantation for
hepatocellular carcinoma (HCC). The precise prediction of post-transplant lung metastasis …

Objective Hepatocellular carcinoma (HCC) has a high rate of postoperative recurrence and
lacks an effective treatment to prevent recurrence. This study aims to investigate the efficacy …

Background: Highly active hepatitis B virus (HBV) is known to be associated with poor
outcomes in patients with hepatocellular carcinoma (HCC). This study aims to investigate …

Background Liver cancer is a serious global health problem and is associated with poor
spiritual health. Bibliotherapy is beneficial in improving health outcomes in cancer patients …

Liver cancer is the fourth leading cause of death worldwide. Well-known risk factors include
hepatitis B virus and hepatitis C virus, along with exposure to aflatoxins, excessive alcohol …

Across the wide range of clinical conditions, there exists a sex imbalance where biological
females are more prone to autoimmune diseases and males to some cancers. These …

Purpose Given that prognosis of hepatocellular carcinoma (HCC) differs dramatically, it is
imperative to uncover effective and available prognostic biomarker (s). The intratumor …

Simple Summary Hepatocellular carcinoma (HCC) remains one of the leading causes of
cancer mortality. Treatment of HCC remains challenging, especially for those with advanced …